Entering text into the input field will update the search result below

DarioHealth receives U.S. FDA clearance for iPhone 7, 8 and Iphone X Smart Glucose Meter; shares ahead 34% premarket

  • DarioHealth (NASDAQ:DRIO) announces that the FDA has granted 510(k) clearance for the Lightning-enabled version of the Dario Blood Glucose Monitoring System which enables the use of the Dario app on iPhone 7, 8 and X smart mobile devices.
  • The launch of Apple's smartphones with only a Lightning connector posed a unique challenge to the entire mobile ecosystem. With market clearance, the company can now offer to U.S. patients its proprietary meter with either a 3.5mm headphone jack or Lightning connector.
  • Shares are up 34% premarket.

Recommended For You

About DRIO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
DRIO--
DarioHealth Corp.